Pedro M Geraldes Selected Research

17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acid

1/2021

Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro M Geraldes Research Topics

Disease

1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2019
1	Insulin Resistance 12/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019

Drug/Important Bio-Agent (IBA)

1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	LipidsIBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Fish OilsIBA 01/2021
1	10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA 01/2021
1	17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2021
1	Type 2 Angiotensin ReceptorIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Insulin (Novolin)FDA Link 12/2019